How Much Does Farxiga Cost in 2026?
Farxiga (dapagliflozin) is a once-daily tablet used for type 2 diabetes, heart failure and chronic kidney disease. Medicare's negotiated price took effect on January 1, 2026: $178 for a 30-day supply, 68% below the $556 list price. In the same year the FDA approved the first true generic dapagliflozin, which makes this the only drug in its class with a generic route, and that route may end up cheaper than the negotiated price.
- Medicare's negotiated price is $178 per 30-day supply, in effect since January 1, 2026, down from a $556 list price. It is the lowest negotiated price of the two SGLT2 inhibitors in the program.
- Generic dapagliflozin was approved in 2026 and is the only generic SGLT2 inhibitor available in the United States.
- On a newly genericized drug the generic frequently undercuts the negotiated price, so ask your pharmacist what the generic costs on your plan and as a cash price before assuming $178 is the floor.
- Your total Medicare Part D out-of-pocket is capped at $2,100 in 2026 across all your drugs, after which covered drugs cost you nothing for the rest of the year.
What You Actually Pay
Figures are for a 30-day supply. List and negotiated prices are from CMS; what you pay depends on your coverage.
| Your situation | Typical cost |
|---|---|
| Medicare negotiated price, 2026 | $178 / 30 days |
| Medicare Part D, your share | up to $2,100 / year |
| Commercial insurance | copay or coinsurance |
| Uninsured, cash | ~$556 (list) |
The Generic Changes the Benchmark
Most of the drugs in the first negotiation round have no generic, so the negotiated price is genuinely the best available number. Farxiga is different. Generic dapagliflozin arrived in 2026, and once several manufacturers are competing on a molecule the price tends to fall far below anything a negotiation produces.
The practical consequence is that $178 is a ceiling to compare against, not a target to aim for. Ask two questions at the pharmacy: what does generic dapagliflozin cost under my plan, and what does it cost as a cash price without running it through insurance. On recently genericized drugs the cash price sometimes beats the insured copay, which is counterintuitive and worth checking. One caveat if you are on Medicare: money you spend outside your plan does not count toward your deductible or the $2,100 cap.
What Medicare's Negotiated Price Does, and Does Not, Change
The headline number is not your copay.
$178 is the maximum fair price, the amount Medicare and your Part D plan pay for a 30-day supply of Farxiga. What you are charged at the counter is still set by your plan's tier and cost-sharing rules.
It helps you directly if you pay coinsurance
Many plans charge a percentage of the drug's price on brand and specialty tiers. If you owe 25% of $556, that is far more than 25% of $178. When your share is a percentage, a lower negotiated price lowers your bill directly.
It may not change a flat copay
If your plan charges a fixed dollar copay for that tier, your copay can stay the same even though the plan is paying less. The benefit then shows up in the program's overall costs rather than your receipt.
It changes how fast you hit the cap
Your spending counts toward the $2,100 annual Part D out-of-pocket cap in 2026. A cheaper drug means a smaller share each month, which can mean you reach the cap later or not at all, so the year-end picture differs from past years.
It does not change coverage rules
A negotiated price does not force a plan to cover Farxiga, drop prior authorization, or change its tier. Plans still set their own formularies, so check yours before you assume the new price applies to you.
Because tiers and cost-sharing vary so much between plans, the only way to know your real cost is to check Farxiga against each plan's formulary. If you would rather have that done for you, our Find My Medicare Plan service checks your specific drugs against the plans available to you for a flat $99.
Is There a Generic for Farxiga?
Yes. The FDA approved the first true generic dapagliflozin in 2026, making Farxiga the only SGLT2 inhibitor with a generic available in the United States. Generic entry normally pushes prices down over time as more manufacturers launch, so ask what the generic costs on your plan rather than assuming the negotiated price is the cheapest option.
Does Insurance Cover Farxiga?
Usually, with conditions
Farxiga is covered by Medicare Part D and most commercial plans, typically on a brand tier, often with prior authorization and sometimes step therapy. Coverage rules can differ by indication, since the drug is approved for type 2 diabetes, heart failure and chronic kidney disease. Now that a generic exists, expect plans to prefer it and to place the brand on a worse tier.
If you are denied or moved a tier
A denial is not the end, and a tier change at renewal is not either. Your prescriber can submit a letter of medical necessity or a formulary exception, and you have formal appeal rights. See how to appeal an insurance denial and what to do when a plan drops your drug.
How to Pay Less
Ask for generic dapagliflozin and compare both prices
It is AB-rated, so your pharmacist can normally substitute it. Compare the generic copay under your plan against the cash price, because newly genericized drugs sometimes cost less outside insurance than through it.
On commercial insurance, check the AstraZeneca savings program
A manufacturer savings card can cut a commercial copay substantially. It cannot be used with Medicare, Medicaid or other federal coverage.
On Medicare, check Extra Help and the payment plan
Extra Help (the Low Income Subsidy) sharply reduces Part D costs and its income limits are higher than most people expect. The Medicare Prescription Payment Plan can also spread your Part D costs evenly across the year instead of front-loading them, and you opt in through your plan.
Check the tier before you commit to a plan
The same drug can cost very different amounts across plans in the same ZIP code. During open enrollment, compare Farxiga on each plan's formulary, and remember the plan that was cheapest last year may not be this year.
Push back on a bill you have already received
If you were billed more than you expected, or a claim was processed wrong, CareRoute Bill Defense reviews and disputes medical bills, with no fee unless we save you money.
Not sure which plan covers Farxiga best?
For a flat $99, we research the Medicare plans available to you and check them against your specific drugs and doctors, then hand you a clear comparison. We are independent, sell no insurance, and take no commissions.
Frequently Asked Questions
Is there a generic for Farxiga?
Yes. The FDA approved the first true generic dapagliflozin in 2026, and it is currently the only generic SGLT2 inhibitor available in the United States. It is AB-rated to Farxiga, so your pharmacist can normally substitute it. Because generic prices usually keep falling as more manufacturers launch, the generic may well cost less than Medicare's $178 negotiated price, so it is worth asking what it costs both through your plan and as a cash price.
Is Farxiga or Jardiance cheaper?
At the Medicare level Farxiga is lower: $178 for a 30-day supply against $197 for Jardiance, both effective January 1, 2026. The more important difference is that generic dapagliflozin became available in 2026 while generic empagliflozin is not expected until about 2029, so Farxiga has a cheaper route that Jardiance does not. Your own copay still depends on your plan's tier for each. The two are not interchangeable: their approved indications and the trial evidence behind each use differ, so the clinical choice belongs with your prescriber.
What is Medicare's negotiated price for Farxiga?
Medicare negotiated a maximum fair price of $178 for a 30-day supply of Farxiga, effective January 1, 2026. That is 68% below the $556 list price CMS used as the comparison. Farxiga was one of the first ten drugs in the Medicare Drug Price Negotiation Program, selected because it was among the highest-spending Part D drugs without generic or biosimilar competition at the time. The price applies automatically at the pharmacy for Part D members.
Will the negotiated price lower what I actually pay for Farxiga?
It can, but it is not your new copay. The maximum fair price is what Medicare and your Part D plan pay the pharmacy, not automatically what you are charged. If your plan charges coinsurance, a percentage of the drug price, a lower negotiated price lowers your share directly. If your plan charges a flat copay for that tier, your copay may not change at all. Either way, your total Part D out-of-pocket is capped at $2,100 in 2026, after which covered drugs cost you nothing for the rest of the year.
Does insurance cover Farxiga?
Generally yes. Farxiga is covered by Medicare Part D and most commercial plans, though plans commonly require prior authorization and sometimes step therapy, meaning you try a cheaper option first. The tier it sits on, not whether it is covered, is usually what decides your cost, and the same drug can sit on different tiers in two plans sold in the same ZIP code. Check your plan's formulary for the tier and any restrictions before you fill it.
Related
Sources
- CMS, Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026 (maximum fair price and list-price comparison)
- CMS / Medicare.gov (Part D out-of-pocket cap, $2,100 in 2026, and the $615 maximum deductible)
- FDA Orange Book and Purple Book (approval and substitutability status for dapagliflozin)
- AstraZeneca published list price and patient-support program terms
Prices are national figures for a 30-day supply at a common dose and vary by pharmacy, dose, and plan. List prices are the figures CMS published as its negotiation comparison. This page is educational and is not medical or financial advice: do not start, stop, or switch a prescription on the basis of price without talking to your prescriber. Last updated November 20, 2026.